Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on HOWDEN JOINERY GROUP PLC. We currently have 15 research reports from 3 professional analysts.
|11Jan17 02:47||RNS||NOTIFICATION OF MAJOR INTEREST IN SHARES|
|03Jan17 09:00||RNS||Voting Rights and Capital|
|14Dec16 12:15||RNS||Director/PDMR Shareholding|
|01Dec16 09:00||RNS||Voting Rights and Capital|
|17Nov16 01:21||RNS||Director/PDMR Shareholding|
|16Nov16 02:01||RNS||Director/PDMR Shareholding|
|03Nov16 07:00||RNS||Trading Statement|
Frequency of research reports
Research reports on
HOWDEN JOINERY GROUP PLC
HOWDEN JOINERY GROUP PLC
N+1 Singer - Morning Song 03-11-2016
03 Nov 16
Overall trading for the year appears to have started slightly slowly overall but with underlying revenues making progress and profits flat for the period. Slow profit progress was already expected due to the previously signalled growth orientated investment being made. A material timing change on a Compliance unit contract, strong growth in AXCO and buoyant Health performance bode well for revenue performance looking forward. Visibility levels are said to be good underpinning managements confidence that the group is on track for the year. Wilmington remains a good play on the growth in global regulation and compliance. BUY
N+1 Singer - Retail - Matthew - Brexit driven forecasts and valuation update
27 Jun 16
Prior to the EU vote, fears of Brexit undermined consumer confidence and spending patterns, and sterling weakened against the US$ and the €. Wider fears for employment, consumer spending and economic slow-down had hit Retail stocks significantly (-10% rel. YTD). Friday’s surprise Brexit vote has impacted Sterling again and will further knock confidence and spending too. The sector came under material further pressure as a result, falling 10% on the day vs the Allshare’s 3%. As noted on Friday, there are 4 stocks in our universe where forecasts are favourably exposed to FX upside risk (BCA, Boohoo, Swallowfield, Walker Greenbank), 5 stocks which we have downgraded (Debenhams, Findel, Halfords, N Brown, Howden Joinery) with the remainder left unchanged including Motor Retailers.
Strong trading in recent 8 weeks. Low end f/casts to edge up
28 Apr 16
We suspected that Howden might have traded well in the most recent couple of months and its trading update is not a disappointment in that regard. Sales increased by c8% in LFL depots, taking the 16 week growth to 6.4% LFL (8.7% total growth). The commentary on pricing (vs FX headwinds) is also encouraging. We therefore anticipate low end forecasts being upgraded by c2% this morning. Alongside the reassurance on margins we would expect the shares to claw back the remainder of the gap (vs the recent 450p low) to our target price of 500p.
28 Apr 16
ACCESSO TECHNOLOGY GRP PLC (ACSO LN) | EARTHPORT PLC (EPO LN) | FISHER(JAMES)& SONS PLC (FSJ LN) | GRESHAM COMPUTING (GHT LN) | HOWDEN JOINERY GROUP PLC (HWDN LN) | NCC GROUP (NCC LN) | OXFORD BIOMEDICA PLC (OXB LN) | REDDE PLC (REDD LN) | SEPURA PLC (SEPU LN) | SYNTHOMER PLC (SYNT LN) | VICTREX (VCT LN)
25 Feb 16
AMINO TECHNOLOGIES PLC (AMO LN) | BODYCOTE PLC (BOY LN) | HOWDEN JOINERY GROUP PLC (HWDN LN), IDOX PLC (IDOX LN) | JAMES FISHER & SONS PLC (FSJ LN), LAVENDON GROUP PLC (LVD LN) | OXFORD PHARMASCIENCE GROUP P (OXP LN) | REDDE PLC (REDD LN) | SPIRENT COMMUNICATIONS PLC (SPT LN) | SUMMIT THERAPEUTICS PLC (SUMM LN) | UBM PLC (UBM LN)
Positioning for future profitable growth
25 Feb 16
Prelims are 3% ahead of expectations, through slightly better LFL growth and slightly less cost growth. Of the £33m YoY PBT growth, c£9m relates to the favourable FX tailwind. Based on current FX rates, we estimate the headwind in FY16 will exceed that, possibly c£11-12m. End markets remain favourable and HWDN is investing in capability to continue profitable expansion – now with a 800 depot target (619 now) and additional trials in Europe. An extra £15m of opex (2.5%) is flagged as part of this investment, not all of which appears to be in the numbers. The higher base in FY could shield consensus forecasts from the mix of FX and opex but maybe not all of it.
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
16 Jan 17
We take a look at the rankings of the various countries in Africa that have a significant exposure to mining. We take the Transparency International corruption rankings as our starting point and modify these for exceptional geology and for current UK government travel warnings. Ghana, Botswana and Namibia come out as our top three, with Eritrea, Kenya and Zimbabwe at the bottom of our rankings.
19 Jan 17
Aggregated Micro Power* (AMPH): Funding for first peaking power plant project (CORP) | The Mission Marketing Group* (TMMG): Positive trading update (CORP) | Cello (CLL): Increasingly backed by, and leveraging, technology (BUY) | 4imprint (FOUR): Growth backed by strong cash flow continues (BUY) | Allergy Therapeutics (AGY): Positive trading update and market share gains drive upgrades (BUY) | Shanta Gold (SHG): Q4 operating results (BUY) | Sound Energy (SOU): Tendrara extended well test result (BUY) | Revolution Bars (RBG): Price target increase (BUY)
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
N+1 Singer - St Ives - Downgrade
19 Jan 17
Marketing activation has been impacted by further decline in grocery retail impacting profit by c£5m. Strategic The Company is also taking this opportunity to revise its guidance for Strategic Marketing as its recovery pace is not running at the planned target rate. PBT falls from N1Se £31.9m to £25m. The Company expects dividend to be held based upon lowered guidance and the implied cash flow performance. There do not appear to be any covenant issues. Forecasts and TP under review and downgrade to Hold. We expect the shares to test the 100p level.
N+1 Singer - Northern lights - Shining prospects for 2017
16 Jan 17
As the birthplace of Stephenson, Armstrong and Swan, the North East of England has a proud history of industrial and technological innovation. Despite local economic challenges, the region’s industrial heritage lives on through continuing success in high end engineering and technology. The recent takeovers of private equity backed SMD (subsea robotics) and Nomad Digital (wi-fi on the railways) are testament to this. The North East has also emerged as a leader in genetics and genomics with an enviable life sciences and healthcare infrastructure. Against this backdrop, we expect the region to continue to throw up attractive IPO candidates to build on the six new listings in the past three years. We expect 2017 to be far kinder to the existing portfolio of North East plcs than 2016 (a year to forget) with recent management changes one important theme for the new year. Our top picks are Hargreaves Services, Quantum Pharma and Zytronic (all N+1 Singer Corporate clients) and we are Buyers of Northgate and Grainger.